Impact of Diet on the Gut-Muscle Axis in Older Adults
Impact of a High-Soluble Fiber Diet on the Gut-Muscle Axis in Older Adults
1 other identifier
interventional
31
1 country
1
Brief Summary
Muscle health declines during aging. One factor that may impact muscle health is the community of bacteria that live in our intestines, but studies aimed at improving muscle health by targeting the gut in older adults are sparse. The primary goal of this study is to use a diet that is enriched in soluble fiber, which is exclusively utilized by gut bacteria to make substances that can impact muscle health, to improve muscle-related measures in older adults.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 24, 2022
CompletedFirst Posted
Study publicly available on registry
September 22, 2022
CompletedStudy Start
First participant enrolled
March 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2025
CompletedJuly 18, 2025
August 1, 2024
2.2 years
August 24, 2022
July 15, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Quantification of SCFAs in fecal samples
Fecal levels of bacterial metabolites, including acetate, propionate, and butyrate will be determined at the baseline and week-13 study visits
Change from baseline when compared with the Week-13 visit
Quantification of whole-body lean mass with DXA
Measurement of whole-body lean mass will be determined at the baseline and week-13 study visits
Change from baseline when compared with the Week-13 visit
Quantification of hand grip strength
Grip strength will be determined at the baseline and week-13 study visits
Change from baseline when compared with the Week-13 visit
Chair stand test
The number of chair stands that can be performed in 30 seconds will be determined at the baseline and week-13 study visits
Change from baseline when compared with the Week-13 visit
Secondary Outcomes (5)
Quantification of thigh muscle composition with computed tomography
Change from baseline when compared with the Week-13 visit
6-minute walk test
Change from baseline when compared with the Week-13 visit
Quantification of gut bacterial metabolites in plasma
Change from baseline when compared with the Week-13 visit
Quantification of gut bacterial composition in fecal samples
Change from baseline when compared with the Week-13 visit
Quantification of pH in fecal samples
Change from baseline when compared with the Week-13 visit
Study Arms (2)
Low-soluble fiber diet
OTHERHigh-soluble fiber diet
ACTIVE COMPARATORInterventions
12 older adults (\>65y) will be randomized to consume the USDA Guidelines for fiber intake (10g of total fiber/1000 calories), as the low-soluble fiber diet
12 older adults (\>65y) will be randomized to consume 34-35g of total fiber/1000 calories, as the high-soluble fiber diet
Eligibility Criteria
You may qualify if:
- Independently living older adults (\> 65y)
- Sedentary (Godin-Shepard Leisure Time Physical Activity Questionnaire score \< 10)
- Non-smoking
- Not already consuming a high-fiber diet (\> 22, 28 g/day for women, men)
- Free of gastrointestinal disease (gastrointestinal cancer, inflammatory bowel disease, bariatric surgery, irritable bowel syndrome)
- Fluent in English
- Willing to attend three study visits (enrollment, baseline, and week-13)
- Willing to consume an abundance of fruits, vegetables, nuts/seeds
- Willing to consume an abundance of soluble fiber-rich foods (broccoli, brussels sprouts, flaxseeds sweetened with dates, lima beans, butternut squash, carrots, collard greens)
- Willing to tolerate mild gastrointestinal discomfort (bloating, belly grumbling, flatulence). Note that all attempts will be made to replace foods that may trigger these issues.
- Willing to not consume antibiotics during the 13-week study
- Willing to not schedule a colonoscopy during the 13-week study
You may not qualify if:
- Unwilling to visit the Tufts Human Nutrition Research Center on Aging (HNRCA) 3x/week to pick up the pre-prepared study diet
- Unwilling to only consume the provided food (unsweetened tea and/or black coffee are allowed)
- Food allergies related to foods that are included in the study
- Chewing problems
- Unwilling to wear a daily step counter (pedometer)
- Unwilling to complete a daily questionnaire that will assess gastrointestinal comfort
- Malnutrition (BMI \< 18.5 kg/m2)
- Use of supplemental probiotics or antibiotics, participation in an investigational drug evaluation, or a recent change in habitual medication use within the 1 month-period prior to the screening visit
- \> 5% weight loss or weight gain within the past 6-months
- A recent history of alcohol abuse (within the past 5 years)
- A history of any significant injury or surgery that currently affects physical functioning and ability to perform physical function testing
- Treatment with immunosuppressive drugs
- A prior diagnosis of organ failure (heart, liver, renal, respiratory)
- Diabetes mellitus (type 1, or type 2 with insulin therapy)
- Chronic kidney disease (eGFR ≤ 30 mL/min/1.73 m2)
- +7 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tufts Universitylead
Study Sites (1)
Jean Mayer Human Nutrition Research Center on Aging at Tufts University
Boston, Massachusetts, 02111, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Michael S Lustgarten, PhD
Scientist II, NEPS Laboratory
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
August 24, 2022
First Posted
September 22, 2022
Study Start
March 1, 2023
Primary Completion
April 30, 2025
Study Completion
April 30, 2025
Last Updated
July 18, 2025
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share
No data from participants will be shared with researchers not affiliated with this project.